Search research articles
Contact Us
Filters
Showing results (801-810 of 856) with videos related to
Page
of 86
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
E Van Cutsem, S Siena, Y Humblet, et al.
Nuclear Medicine and Biology
|
August 1, 1996
123I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract
I Virgolini, M Raderer, A Kurtaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities
Jan C Buckner, Dean Gesme, Judith R O'Fallon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 18, 2005
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease
S J Pittock, R L McClelland, S J Achenbach, et al.
Ultrastructural Pathology
|
January 23, 2003
Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study
O Kurtkaya-Yapicier, B W Scheithauer, J A Carney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2012
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306
S Stintzing, L Fischer von Weikersthal, T Decker, et al.
European Journal of Clinical Investigation
|
November 9, 2012
ACTH-secreting Crooke cell carcinoma of the pituitary
Gábor L Kovács, Miklós Góth, Fabio Rotondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results
E Galanis, J C Buckner, P A Burch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 26, 2006
Central neurocytoma: management recommendations based on a 35-year experience
James L Leenstra, Fausto J Rodriguez, Christina M Frechette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients
C H Köhne, D Cunningham, F Di Costanzo, et al.
Page
of 86
Search research articles
Search
Showing results (801-810 of 856) with videos related to
Sort By:
Page
of 86
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
E Van Cutsem, S Siena, Y Humblet, et al.
Nuclear Medicine and Biology
|
August 1, 1996
123I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract
I Virgolini, M Raderer, A Kurtaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities
Jan C Buckner, Dean Gesme, Judith R O'Fallon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 18, 2005
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease
S J Pittock, R L McClelland, S J Achenbach, et al.
Ultrastructural Pathology
|
January 23, 2003
Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study
O Kurtkaya-Yapicier, B W Scheithauer, J A Carney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2012
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306
S Stintzing, L Fischer von Weikersthal, T Decker, et al.
European Journal of Clinical Investigation
|
November 9, 2012
ACTH-secreting Crooke cell carcinoma of the pituitary
Gábor L Kovács, Miklós Góth, Fabio Rotondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results
E Galanis, J C Buckner, P A Burch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 26, 2006
Central neurocytoma: management recommendations based on a 35-year experience
James L Leenstra, Fausto J Rodriguez, Christina M Frechette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients
C H Köhne, D Cunningham, F Di Costanzo, et al.
Page
of 86